A listed technology-based company focused on peptide chemistry. The company provides a full range of services to the pharma and biotech industries. It specializes in the development of innovative, efficient manufacturing processes and the reliable production of peptide-based active pharmaceutical ingredients. A comprehensive catalog of biochemicals and exclusive custom syntheses for research labs complete the service portfolio. Headquartered in Switzerland with subsidiaries in Europe and the US, the group has a global reach with more experience and know-how than any other company in the industry. Towards its customers, Bachem shows total commitment to quality, innovation and partnership. https://www.bachem.com
Hoffmann & Co AG
A leading independent professional services company based in Switzerland, offering a unique, integrated services model in the complex and specialist areas of valuations and mergers and acquisitions. We, the partners – Kaspar Kunz, Dr. Urs Breitenstein, Thomas Wenk, Marc Hoffmann und Patrick Schacher – attach great importance to deliver innovative solutions with true professionalism, commitment, transparency, integrity and personal customer care.
A governmental body promoting the connectivity between Italian tech-clusters and international partners. In the field of Health-Biotech, ITA promotes transnational cooperation in manufacturing and R&D. This is achieved by supporting match-making in Italy, and through ITA’s 80 world-wide offices also internationally. ITA serves as a one-stop window for international companies requiring support in doing business in Italy.
As more than 60% of new drugs fail in phase 2, we have chosen to focus our activities since 2000 on preclinical in Vivo Efficacy Studies to offer better predictability and anticipate clinical results. Syncrosome offer relevant disease models, cutting-edge techniques, specific Biomarkers and a comprehensive background of physiopathology to assist drug discovery companies in selecting their compounds.
We have developped and validated so far more than 15 disease models, and our flexible and human-sized organization can design and operate tailored in vivo experimental protocols to give you appropriate answers.